0.6952
price down icon3.44%   -0.0248
pre-market  Pre-mercato:  .72   0.0248   +3.57%
loading

Genprex Inc Azioni (GNPX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
11.81%
3.2744
3.713 4.6165 3.9769 5.3101
Costs And Expenses
0.17%
5.9967
5.9867 7.7863 8.0357 9.2712
Operating Income/Loss
0.17%
-5.9967
-5.9867 -7.7863 -8.0357 -9.2712
Income/Loss From Continuing Operations Before Tax
0.17%
-5.9967
-5.9867 -7.7863 -7.9802 -9.2028
Income/Loss From Continuing Operations After Tax
0.67%
-5.9689
-5.9293 -7.7482 -7.9802 -9.2028
Net Income/Loss
0.67%
-5.9689
-5.9293 -7.7482 -7.9802 -9.2028
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
103.13%
1.6182
-51.75 57.81 51.98 49.47
Basic Earnings Per Share
83.30%
-3.69
-22.09 -0.13 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):